Cost-Benefit Analysis Clinical Trial
Official title:
Targeted Sequencing to Enhance, Liberate, and Optimize Treatment of Drug-resistant Tuberculosis
TS ELiOT is a stepped-wedge, cluster randomized trial assessing the effect of a next-generation sequencing-based strategy on rifampin-resistant tuberculosis management and patient outcomes.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05017324 -
Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial
|
N/A | |
| Active, not recruiting |
NCT04179500 -
A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis Volunteers
|
Phase 2 | |
| Recruiting |
NCT06224036 -
Clinical Study of JDB0131 Benzenesulfonate Tablets in Patients With Drug-sensitive Pulmonary Tuberculosis
|
Phase 2 | |
| Completed |
NCT02234908 -
Rewards for Tuberculosis Contact Screening
|
N/A | |
| Completed |
NCT02236078 -
Brief Bactericidal Activity of Anti-Tuberculosis Drugs
|
Phase 1 | |
| Completed |
NCT04147676 -
Evaluation of Centralised TB Assay Solutions
|
||
| Completed |
NCT04493671 -
Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults
|
Phase 1 | |
| Completed |
NCT03338621 -
Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients
|
Phase 2/Phase 3 | |
| Completed |
NCT05526911 -
A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults
|
Phase 1 | |
| Completed |
NCT03266003 -
An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment
|
N/A | |
| Completed |
NCT04119375 -
Behavior Change and Digital Health Interventions for Improved TB Treatment Outcomes
|
N/A |